Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
第一作者:
Catriona,Waitt
第一单位:
Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.;Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda.;Royal Liverpool University Hospital, Liverpool, United Kingdom.
作者:
医学主题词
成年人(Adult);炔类(Alkynes);苯并恶嗪类(Benzoxazines);环丙烷类(Cyclopropanes);女(雌)性(Female);HIV(HIV);HIV感染(HIV Infections);HIV整合酶抑制剂(HIV Integrase Inhibitors);杂环化合物, 3环(Heterocyclic Compounds, 3-Ring);人类(Humans);婴儿, 新生(Infant, Newborn);传染性疾病传播, 垂直(Infectious Disease Transmission, Vertical);母体胎儿间交换(Maternal-Fetal Exchange);乳, 人(Milk, Human);恶嗪类(Oxazines);哌嗪类(Piperazines);妊娠(Pregnancy);吡啶酮类(Pyridones);逆转录酶抑制剂(Reverse Transcriptase Inhibitors);危险性评估(Risk Assessment);南非(South Africa);治疗结果(Treatment Outcome);乌干达(Uganda);病毒载量(Viral Load);青年人(Young Adult)
DOI
10.1371/journal.pmed.1002895
PMID
31539371
发布时间
2025-05-30
- 浏览2
PLoS medicine
e1002895页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



